British Approved Names are short, distinctive names selected in accordance with the Guiding Principles for substances the systematic chemical or other scientific names of which are too complex for convenient general use. British Approved Names are devised or selected by the British Pharmacopoeia Commission and published by the Health Ministers on the recommendation of the Commission of Human Medicines to provide a list of names of substances or articles referred to in section 100 of the Medicines Act 1968.
The Blue Guide: Advertising and Promotion of Medicines in the UK
2nd rev. ed.
Medicines and Healthcare products Regulatory Agency (MHRA)
The guide updates guidance on the promotion of medicines and reflects the changes that have occurred in legislation governing the advertising of medicines and the developments that have taken place in the MHRA's policy and procedures. It also takes account of the Government's response to the Health Committee's report on the advertising of new active substances (HCP 42-I, session 04-05, The Influence of the Pharmaceutical Industry: 4th report - ISBN 0215023900).
Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2007
Medicines and Healthcare products Regulatory Agency (MHRA)
Popularly known as The Orange Guide, 'Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2007', contains up-to-date information on European and UK guidance and legislation, an essential guide for all who manufacture or distribute medicines.